Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (461-470 of 768) with videos related to

Pageof 77
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2017
Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy OutcomesJonathan E Brammer, Dai Chihara, L Michelle Poon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2017
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaAnkur Varma, Laura Biritxinaga, Rima M Saliba, et al.
Bone Marrow Transplantation|March 23, 2011
Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CRU Popat, M J de Lima, R M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
European Journal of Haematology|January 17, 2016
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvementTalha Badar, Amanda Megan Cornelison, Nina D Shah, et al.
Leukemia & Lymphoma|July 28, 2010
Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapyQaiser Bashir, Marcos J De Lima, John D McMannis, et al.
Bone Marrow Transplantation|June 27, 2012
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALLP Kebriaei, T Madden, X Wang, et al.
Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature reviewDavid S Hong, Kalen L Jacobson, Issam I Raad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2013
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantationLi Mei Poon, Amir Hamdi, Rima Saliba, et al.
Pageof 77

Showing results (461-470 of 768) with videos related to

Sort By:
Pageof 77
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2017
Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy OutcomesJonathan E Brammer, Dai Chihara, L Michelle Poon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2017
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaAnkur Varma, Laura Biritxinaga, Rima M Saliba, et al.
Bone Marrow Transplantation|March 23, 2011
Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CRU Popat, M J de Lima, R M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2011
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignanciesJakob R Passweg, Mei-Jie Zhang, Vanderson Rocha, et al.
European Journal of Haematology|January 17, 2016
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvementTalha Badar, Amanda Megan Cornelison, Nina D Shah, et al.
Leukemia & Lymphoma|July 28, 2010
Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapyQaiser Bashir, Marcos J De Lima, John D McMannis, et al.
Bone Marrow Transplantation|June 27, 2012
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALLP Kebriaei, T Madden, X Wang, et al.
Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2003
West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature reviewDavid S Hong, Kalen L Jacobson, Issam I Raad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2013
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantationLi Mei Poon, Amir Hamdi, Rima Saliba, et al.
Pageof 77